Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Publications > Meeting Minutes > Clinical Studies Committee

Clinical Studies Committee

MINUTES OF 57TH MEETING OF CLINICAL STUDIES COMMITTEE HELD ON 20th MAY, 2025.

Abdul Qadir Clinical Studies Committee June 5, 2025June 5, 2025
documentDownload

Minutes of 51st Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee November 5, 2024November 7, 2024
51.-Minutes-of-the-51st-CSC-Meeting-24-10-2024-SummaryDownload

Minutes of 50th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee August 13, 2024November 7, 2024
50.-Minutes-of-the-50th-CSC-Meeting-11-07-2024-SummaryDownload

Minutes of 49th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee July 24, 2024November 7, 2024
49.-Minutes-of-the-49th-CSC-Meeting-16-05-2024-SummaryDownload

Minutes of 48th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee April 30, 2024November 7, 2024
48.-Minutes-of-the-48th-CSC-Meeting-28-03-2024-SummaryDownload

Minutes of 47th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee February 5, 2024November 6, 2024
47.-Minutes-of-the-47th-CSC-Meeting-22-12-2023-SummaryDownload

Minutes of 46th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee November 30, 2023November 6, 2024
46.-Minutes-of-the-46th-CSC-Meeting-27-10-2023-SummaryDownload

Minutes of 45th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee November 17, 2023November 6, 2024
45.-Minutes-of-the-45th-CSC-Meeting-13-10-2023-SummaryDownload

Minutes of 44th Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee October 6, 2023November 6, 2024
44.-Minutes-of-the-44th-CSC-Meeting-25-08-2023-SummaryDownload

Minutes of 43rd Meeting of Clinical Studies Committee

Asad Ullah Clinical Studies Committee August 6, 2023November 6, 2024

43.-Minutes-of-the-43rd-CSC-Meeting-25-08-2023-SummaryDownload
  • ← Previous
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Open Consultations
    • Closed Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem